Citations (65)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Song Yang, Shadma Wahab, Mohammad Ali Abdullah Almoyad, Yanxin Chen, Nida Kalam & Mohammad Khalid. (2023) Discovery of promising B lymphocyte kinase inhibitors using structure-guided virtual screening. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-11.
Read now
Read now
Su’an Tang, Qinghong Yu & Changhai Ding. (2022) Investigational spleen tyrosine kinase (SYK) inhibitors for the treatment of autoimmune diseases. Expert Opinion on Investigational Drugs 31:3, pages 291-303.
Read now
Read now
Deepa K. Ingawale & Satish K. Mandlik. (2020) New insights into the novel anti-inflammatory mode of action of glucocorticoids. Immunopharmacology and Immunotoxicology 42:2, pages 59-73.
Read now
Read now
Maninder Kaur & Om Silakari. (2017) Ligand-based and e-pharmacophore modeling, 3D-QSAR and hierarchical virtual screening to identify dual inhibitors of spleen tyrosine kinase (Syk) and janus kinase 3 (JAK3). Journal of Biomolecular Structure and Dynamics 35:14, pages 3043-3060.
Read now
Read now
Leslie J. Crofford, Lindsay E. Nyhoff, Jonathan H. Sheehan & Peggy L. Kendall. (2016) The role of Bruton’s tyrosine kinase in autoimmunity and implications for therapy. Expert Review of Clinical Immunology 12:7, pages 763-773.
Read now
Read now
Anna Korycka-Wołowiec, Dariusz Wołowiec & Tadeusz Robak. (2015) Pharmacodynamic considerations of small molecule targeted therapy for treating B-cell malignancies in the elderly. Expert Opinion on Drug Metabolism & Toxicology 11:9, pages 1371-1391.
Read now
Read now
Pawel Robak, Piotr Smolewski & Tadeusz Robak. (2015) Emerging immunological drugs for chronic lymphocytic leukemia. Expert Opinion on Emerging Drugs 20:3, pages 423-447.
Read now
Read now
Karen Wai, Lisa Marie Saldanha, Elvira Zenaida Lansang, Saumya Nayak, Anish Sule & Ken J Lee. (2013) Case series of feasibility considerations that impact operational delivery strategy in the highly competitive rheumatoid arthritis space in Asia. Open Access Journal of Clinical Trials 5, pages 33-38.
Read now
Read now
Tadeusz Robak & Pawel Robak. (2013) BCR Signaling in Chronic Lymphocytic Leukemia and Related Inhibitors Currently in Clinical Studies. International Reviews of Immunology 32:4, pages 358-376.
Read now
Read now
Anna Korycka-Wołowiec & Tadeusz Robak. (2012) Pharmacokinetic evaluation and therapeutic activity of bendamustine in B-cell lymphoid malignancies. Expert Opinion on Drug Metabolism & Toxicology 8:11, pages 1455-1468.
Read now
Read now
Articles from other publishers (55)
Zhaozhao Wang, Shu Qu, Jiahao Yuan, Wen Tian, Jinglei Xu, Rui Tao, Shilong Sun, Tao Lu, Weifang Tang & Yong Zhu. (2023) Review and prospects of targeted therapies for Spleen tyrosine kinase (SYK). Bioorganic & Medicinal Chemistry 96, pages 117514.
Crossref
Crossref
Mengjuan Li, Liu Liu, Bingjie Ding, Xuewen Song, Ao Xia, Yu Han, Yongping Song, Xudong Wei & Hu Zhou. (2022) Refractory/relapse thrombocytopenia in a patient with Evans' syndrome successfully treated with zanubrutinib. British Journal of Haematology 199:5.
Crossref
Crossref
Shiyang Zhou & Gangliang Huang. (2022) Some important inhibitors and mechanisms of rheumatoid arthritis. Chemical Biology & Drug Design 99:6, pages 930-943.
Crossref
Crossref
Hui Qiu, Zahid Ali, Julian Bowlan, Richard Caldwell, Anna Gardberg, Nina Glaser, Andreas Goutopoulos, Jared Head, Theresa Johnson, Christine Maurer, Katrin Georgi, Roland Grenningloh, Zhizhou Fang, Federica Morandi, Felix Rohdich, Ralf. Schmidt, Ariele Viacava Follis & Brian Sherer. (2021) Discovery of Covalent Bruton's Tyrosine Kinase Inhibitors with Decreased CYP2C8 Inhibitory Activity. ChemMedChem 16:24, pages 3653-3662.
Crossref
Crossref
Zhicheng Xie, Caigui Xiang, Xin Li, Chen Fan, Taiwen Chen, Moting Liu, Yanjie Ma, Fang Bai, Wei Tang & Youhong Hu. (2021)
Discovery of Potent Antiallergic Agents Based on an
o
-Aminopyridinyl Alkynyl Scaffold
. Journal of Medicinal Chemistry 64:18, pages 13588-13603.
Crossref
Crossref
Somayye Taghvaei, Farzaneh Sabouni & Zarrin Minuchehr. (2021) Evidence of Omics, Immune Infiltration, and Pharmacogenomic for SENP1 in the Pan-Cancer Cohort. Frontiers in Pharmacology 12.
Crossref
Crossref
Hui Qiu, Zahid Ali, Andrew Bender, Richard Caldwell, Yi-Ying Chen, Zhizhou Fang, Anna Gardberg, Nina Glaser, Anja Goettsche, Andreas Goutopoulos, Roland Grenningloh, Bettina Hanschke, Jared Head, Theresa Johnson, Christopher Jones, Reinaldo Jones, Shashank Kulkarni, Christine Maurer, Federica Morandi, Constantin Neagu, Sven Poetzsch, Justin Potnick, Ralf Schmidt, Katherine Roe, Ariele Viacava Follis, Carolyn Wing, Xiaohua Zhu & Brian Sherer. (2021) Discovery of potent and selective reversible Bruton’s tyrosine kinase inhibitors. Bioorganic & Medicinal Chemistry 40, pages 116163.
Crossref
Crossref
Hye Suk Baek, Victor Sukbong Hong, Sang Hyon Kim, Jinho Lee & Shin Kim. (2021) KMU-1170, a Novel Multi-Protein Kinase Inhibitor, Suppresses Inflammatory Signal Transduction in THP-1 Cells and Human Osteoarthritic Fibroblast-Like Synoviocytes by Suppressing Activation of NF-κB and NLRP3 Inflammasome Signaling Pathway. International Journal of Molecular Sciences 22:3, pages 1194.
Crossref
Crossref
A. A. Danilenko, S. V. Shakhtarina & N. A. Falaleeva. (2020) MODERN APPROACHES TO TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA. Siberian journal of oncology 19:6, pages 106-118.
Crossref
Crossref
Jaleh Varshosaz, Saeedeh Fardshouraki, Mina Mirian, Leila Safaeian, Setareh Jandaghian & Somayeh Taymouri. (2020) Encapsulation of Imatinib in Targeted KIT-5 Nanoparticles for Reducing its Cardiotoxicity and Hepatotoxicity. Anti-Cancer Agents in Medicinal Chemistry 20:16, pages 1966-1980.
Crossref
Crossref
Nathaniel Edward Bennett Saidu, Chiara Bonini, Anne Dickinson, Magdalena Grce, Marit Inngjerdingen, Ulrike Koehl, Antoine Toubert, Robert Zeiser & Sara Galimberti. (2020) New Approaches for the Treatment of Chronic Graft-Versus-Host Disease: Current Status and Future Directions. Frontiers in Immunology 11.
Crossref
Crossref
Brigitte Bauvois, Elodie Pramil, Ludovic Jondreville, Elise Chapiro, Claire Quiney, Karim Maloum, Santos A. Susin & Florence Nguyen-Khac. (2020) Relation of Neutrophil Gelatinase-Associated Lipocalin Overexpression to the Resistance to Apoptosis of Tumor B Cells in Chronic Lymphocytic Leukemia. Cancers 12:8, pages 2124.
Crossref
Crossref
Vitale, Montalbano, Salvetti, Boccellato, Griggio, Boccadoro & Coscia. (2020) Autoimmune Complications in Chronic Lymphocytic Leukemia in the Era of Targeted Drugs. Cancers 12:2, pages 282.
Crossref
Crossref
Hui Qiu, Richard Caldwell, Lesley Liu‐Bujalski, Andreas Goutopoulos, Reinaldo Jones, Justin Potnick, Brian Sherer, Andrew Bender, Roland Grenningloh, Daigen Xu, Anna Gardberg, Igor Mochalkin, Theresa Johnson, Ariele Viacava Follis, Jared Head & Federica Morandi. (2019) Discovery of Affinity‐Based Probes for Btk Occupancy Assays. ChemMedChem 14:2, pages 217-223.
Crossref
Crossref
Carol Moreno, Carolina Cuellar & Eva Puy Vicente. 2019. Chronic Lymphocytic Leukemia. Chronic Lymphocytic Leukemia
123
136
.
Hui Qiu, Lesley Liu-Bujalski, Richard D. Caldwell, Ariele Viacava Follis, Anna Gardberg, Andreas Goutopoulos, Roland Grenningloh, Jared Head, Theresa Johnson, Christopher C.V. Jones, Reinaldo Jones, Igor Mochalkin, Federica Morandi, Constantin Neagu, Justin Potnick & Brian Sherer. (2018) Optimization of the efflux ratio and permeability of covalent irreversible BTK inhibitors. Bioorganic & Medicinal Chemistry Letters 28:20, pages 3307-3311.
Crossref
Crossref
Lingchuan Guo, Pei Lin, Hui Xiong, Shichun Tu & Gang Chen. (2018) Molecular heterogeneity in diffuse large B-cell lymphoma and its implications in clinical diagnosis and treatment. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1869:2, pages 85-96.
Crossref
Crossref
James J. Crawford, Adam R. Johnson, Dinah L. Misner, Lisa D. Belmont, Georgette Castanedo, Regina Choy, Melis Coraggio, Liming Dong, Charles Eigenbrot, Rebecca Erickson, Nico Ghilardi, Jonathan Hau, Arna Katewa, Pawan Bir Kohli, Wendy Lee, Joseph W. Lubach, Brent S. McKenzie, Daniel F. Ortwine, Leah Schutt, Suzanne Tay, BinQing Wei, Karin Reif, Lichuan Liu, Harvey Wong & Wendy B. Young. (2018) Discovery of GDC-0853: A Potent, Selective, and Noncovalent Bruton’s Tyrosine Kinase Inhibitor in Early Clinical Development. Journal of Medicinal Chemistry 61:6, pages 2227-2245.
Crossref
Crossref
Peter J. Tonge. (2017) Drug–Target Kinetics in Drug Discovery. ACS Chemical Neuroscience 9:1, pages 29-39.
Crossref
Crossref
Patricia Y. Akinfenwa, Wesley S. Bond, Cristhian J. Ildefonso, Mary Y. Hurwitz & Richard L. Hurwitz. (2017) Versican G1 domain enhances adenoviral-mediated transgene expression and can be modulated by inhibitors of the Janus kinase (JAK)/STAT and Src family kinase pathways. Journal of Biological Chemistry 292:35, pages 14381-14390.
Crossref
Crossref
Maninder Kaur, Manjinder Singh & Om Silakari. (2017) Oxindole-based SYK and JAK3 dual inhibitors for rheumatoid arthritis: designing, synthesis and biological evaluation. Future Medicinal Chemistry 9:11, pages 1193-1211.
Crossref
Crossref
Xiaojing Wang, James Barbosa, Peter Blomgren, Meire C. Bremer, Jacob Chen, James J. Crawford, Wei Deng, Liming Dong, Charles Eigenbrot, Steve Gallion, Jonathon Hau, Huiyong Hu, Adam R. Johnson, Arna Katewa, Jeffrey E. Kropf, Seung H. Lee, Lichuan Liu, Joseph W. Lubach, Jen Macaluso, Pat Maciejewski, Scott A. Mitchell, Daniel F. Ortwine, Julie DiPaolo, Karin Reif, Heleen Scheerens, Aaron Schmitt, Harvey Wong, Jin-Ming Xiong, Jianjun Xu, Zhongdong Zhao, Fusheng Zhou, Kevin S. Currie & Wendy B. Young. (2017) Discovery of Potent and Selective Tricyclic Inhibitors of Bruton’s Tyrosine Kinase with Improved Druglike Properties. ACS Medicinal Chemistry Letters 8:6, pages 608-613.
Crossref
Crossref
F Yesim Demirci, Xingbin Wang, David L Morris, Eleanor Feingold, Sasha Bernatsky, Christian Pineau, Ann Clarke, Rosalind Ramsey-Goldman, Susan Manzi, Timothy J Vyse & M Ilyas Kamboh. (2017) Multiple signals at the extended 8p23 locus are associated with susceptibility to systemic lupus erythematosus. Journal of Medical Genetics 54:6, pages 381-389.
Crossref
Crossref
Ilaria Laurenzana, Antonella Caivano, Francesco La Rocca, Stefania Trino, Luciana De Luca, Francesca D’Alessio, Silvia Schenone, Geppino Falco, Maurizio Botta, Luigi Del Vecchio & Pellegrino Musto. (2016) A Pyrazolo[3,4-d]pyrimidine Compound Reduces Cell Viability and Induces Apoptosis in Different Hematological Malignancies. Frontiers in Pharmacology 7.
Crossref
Crossref
Xianhui Wang, Jason Wong, Christopher J. Sevinsky, Leila Kokabee, Faiza Khan, Yan Sun & Douglas S. Conklin. (2016) Bruton's Tyrosine Kinase Inhibitors Prevent Therapeutic Escape in Breast Cancer Cells. Molecular Cancer Therapeutics 15:9, pages 2198-2208.
Crossref
Crossref
Güray Can, Süleyman Ayvaz, Hatice Can, İhsan Karaboğa, Selim Demirtaş, Hasan Akşit, Bülent Yılmaz, Uğur Korkmaz, Mevlüt Kurt & Turan Karaca. (2016) The efficacy of tyrosine kinase inhibitor dasatinib on colonic mucosal damage in murine model of colitis. Clinics and Research in Hepatology and Gastroenterology 40:4, pages 504-516.
Crossref
Crossref
Lindsay E. Nyhoff, Bridgette L. Barron, Elizabeth M. Johnson, Rachel H. Bonami, Damian Maseda, Benjamin A. Fensterheim, Wei Han, Timothy S. Blackwell, Leslie J. Crofford & Peggy L. Kendall. (2016) Bruton's Tyrosine Kinase Deficiency Inhibits Autoimmune Arthritis in Mice but Fails to Block Immune Complex-Mediated Inflammatory Arthritis. Arthritis & Rheumatology 68:8, pages 1856-1868.
Crossref
Crossref
Mohamed Ali Seyed, Ibrahim Jantan, Syed Nasir Abbas Bukhari & Kavitha Vijayaraghavan. (2016) A Comprehensive Review on the Chemotherapeutic Potential of Piceatannol for Cancer Treatment, with Mechanistic Insights. Journal of Agricultural and Food Chemistry 64:4, pages 725-737.
Crossref
Crossref
Wendy B. Young, James Barbosa, Peter Blomgren, Meire C. Bremer, James J. Crawford, Donna Dambach, Charles Eigenbrot, Steve Gallion, Adam R. Johnson, Jeffrey E. Kropf, Seung H. Lee, Lichuan Liu, Joseph W. Lubach, Jen Macaluso, Pat Maciejewski, Scott A. Mitchell, Daniel F. Ortwine, Julie Di Paolo, Karin Reif, Heleen Scheerens, Aaron Schmitt, Xiaojing Wang, Harvey Wong, Jin-Ming Xiong, Jianjun Xu, Christine Yu, Zhongdong Zhao & Kevin S. Currie. (2016) Discovery of highly potent and selective Bruton’s tyrosine kinase inhibitors: Pyridazinone analogs with improved metabolic stability. Bioorganic & Medicinal Chemistry Letters 26:2, pages 575-579.
Crossref
Crossref
Minhang Xin, Xinge Zhao, Wei Huang, Qiu Jin, Gang Wu, Yazhou Wang, Feng Tang & Hua Xiang. (2015) Synthesis and biological evaluation of novel 7-substituted 3-(4-phenoxyphenyl)thieno[3,2-c]pyridin-4-amines as potent Bruton’s tyrosine kinase (BTK) inhibitors. Bioorganic & Medicinal Chemistry 23:19, pages 6250-6257.
Crossref
Crossref
Xinge Zhao, Minhang Xin, Yazhou Wang, Wei Huang, Qiu Jin, Feng Tang, Gang Wu, Yong Zhao & Hua Xiang. (2015) Discovery of thieno[3,2- c ]pyridin-4-amines as novel Bruton’s tyrosine kinase (BTK) inhibitors. Bioorganic & Medicinal Chemistry 23:17, pages 6059-6068.
Crossref
Crossref
Shoichi Kaneshiro, Kosuke Ebina, Kenrin Shi, Kiyoshi Yoshida, Dai Otsuki, Hideki Yoshikawa & Chikahisa Higuchi. (2014) Bruton tyrosine kinase (Btk) suppresses osteoblastic differentiation. Journal of Bone and Mineral Metabolism 33:5, pages 486-495.
Crossref
Crossref
Doriano Fabbro, Sandra W Cowan‐Jacob & Henrik Moebitz. (2015)
Ten things you should know about protein kinases:
IUPHAR R
eview 14
. British Journal of Pharmacology 172:11, pages 2675-2700.
Crossref
Crossref
Irene Guendel, Sergey Iordanskiy, Gavin C. Sampey, Rachel Van Duyne, Valerie Calvert, Emanuel Petricoin, Mohammed Saifuddin, Kylene Kehn-Hall & Fatah Kashanchi. (2015) Role of Bruton’s tyrosine kinase inhibitors in HIV-1-infected cells. Journal of NeuroVirology 21:3, pages 257-275.
Crossref
Crossref
Nadine KutschReinhard MarksRichard RateiThomas K. HeldMartin Schmidt-Hieber. (2015) Role of Tyrosine Kinase Inhibitors in Indolent and Other Mature B-Cell Neoplasms. Biomarker Insights 10s3, pages BMI.S22434.
Crossref
Crossref
Xinge Zhao, Minhang Xin, Wei Huang, Yanliang Ren, Qiu Jin, Feng Tang, Hailong Jiang, Yazhou Wang, Jie Yang, Shifu Mo & Hua Xiang. (2015) Design, synthesis and evaluation of novel 5-phenylpyridin-2(1H)-one derivatives as potent reversible Bruton’s tyrosine kinase inhibitors. Bioorganic & Medicinal Chemistry 23:2, pages 348-364.
Crossref
Crossref
Norman Latov. (2014) Diagnosis and treatment of chronic acquired demyelinating polyneuropathies. Nature Reviews Neurology 10:8, pages 435-446.
Crossref
Crossref
Yiming Zhong, John C. Byrd & Jason A. Dubovsky. (2014) The B-Cell Receptor Pathway: A Critical Component of Healthy and Malignant Immune Biology. Seminars in Hematology 51:3, pages 206-218.
Crossref
Crossref
Vassilis Mavromatidis, Zoltan Varga, Frigyes Waczek, Zoltán Őrfi, László Őrfi, György Kéri & George Mosialos. (2014) Identification of Protein Kinase Inhibitors with a Selective Negative Effect on the Viability of Epstein-Barr Virus Infected B Cell Lines. PLoS ONE 9:4, pages e95688.
Crossref
Crossref
Tadeusz Robak. (2014) New horizons in the treatment of chronic lymphocytic leukemia. Acta Haematologica Polonica 45:2, pages 122-131.
Crossref
Crossref
H Patterson, R Nibbs, I McInnes & S Siebert. (2014) Protein kinase inhibitors in the treatment of inflammatory and autoimmune diseases. Clinical and Experimental Immunology 176:1, pages 1-10.
Crossref
Crossref
Eva Baecklund, Karin E. Smedby, Lesley-Ann Sutton, Johan Askling & Richard Rosenquist. (2014) Lymphoma development in patients with autoimmune and inflammatory disorders – What are the driving forces?. Seminars in Cancer Biology 24, pages 61-70.
Crossref
Crossref
Dmitriy M. Volochnyuk, Oleksandr O. Grygorenko & Alina O. Gorlova. 2014. Fluorine in Heterocyclic Chemistry Volume 2. Fluorine in Heterocyclic Chemistry Volume 2
577
672
.
Michael R. Grever. (2013) Accelerating safe drug development: an ideal approach to approval. Hematology 2013:1, pages 24-29.
Crossref
Crossref
Yu-Tzu Tai & Kenneth C. Anderson. 2013. Myeloma. Myeloma
110
120
.
Carsten U. Niemann & Adrian Wiestner. (2013) B-cell receptor signaling as a driver of lymphoma development and evolution. Seminars in Cancer Biology 23:6, pages 410-421.
Crossref
Crossref
Wasif N. Khan, Jacqueline A. Wright, Eden Kleiman, Justin C. Boucher, Iris Castro & Emily S. Clark. (2013) B-lymphocyte tolerance and effector function in immunity and autoimmunity. Immunologic Research 57:1-3, pages 335-353.
Crossref
Crossref
Andrew J.K. Williamson, Andrew Pierce, Ewa Jaworska, Cong Zhou, Mark Aspinall-O'Dea, Lee Lancashire, Richard D. Unwin, Sheela A. Abraham, Michael J. Walker, Sara Cadecco, Elaine Spooncer, Tessa L. Holyoake & Anthony D. Whetton. (2013) A Specific PTPRC/CD45 Phosphorylation Event Governed by Stem Cell Chemokine CXCL12 Regulates Primitive Hematopoietic Cell Motility. Molecular & Cellular Proteomics 12:11, pages 3319-3329.
Crossref
Crossref
Elaine F. Kenny, Susan R. Quinn, Sarah L. Doyle, Paul M. Vink, Hans van Eenennaam & Luke A. J. O’Neill. (2013) Bruton’s Tyrosine Kinase Mediates the Synergistic Signalling between TLR9 and the B Cell Receptor by Regulating Calcium and Calmodulin. PLoS ONE 8:8, pages e74103.
Crossref
Crossref
L. Vargas, A. Hamasy, B. F. Nore & C. I. E. Smith. (2013) Inhibitors of BTK and ITK: State of the New Drugs for Cancer, Autoimmunity and Inflammatory Diseases. Scandinavian Journal of Immunology 78:2, pages 130-139.
Crossref
Crossref
Seng-Lai Tan, Cheng Liao, Matthew C. Lucas, Christopher Stevenson & Julie A. DeMartino. (2013) Targeting the SYK–BTK axis for the treatment of immunological and hematological disorders. Pharmacology & Therapeutics 138:2, pages 294-309.
Crossref
Crossref
Jiri Kovarik. (2013) From Immunosuppression to Immunomodulation: Current Principles and Future Strategies. Pathobiology 80:6, pages 275-281.
Crossref
Crossref
Russell T. Naven, Sheila Kantesaria, Sashi Nadanaciva, Thomas Schroeter & Karen L. Leach. (2013) High throughput glutathione and Nrf2 assays to assess chemical and biological reactivity of cysteine-reactive compounds. Toxicology Research 2:4, pages 235.
Crossref
Crossref
Robert D. Riehle, Sinziana Cornea & Alexei Degterev. 2013. Lipid-mediated Protein Signaling. Lipid-mediated Protein Signaling
105
139
.
Carsten U. Niemann, Jade Jones & Adrian Wiestner. 2013. Advances in Chronic Lymphocytic Leukemia. Advances in Chronic Lymphocytic Leukemia
259
291
.